Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Statement re Prospectus and Circular

20 Oct 2014 18:27

RNS Number : 8172U
Maven Income & Growth VCT PLC
20 October 2014
 



Joint Announcement

Prospectus and Circular

Maven Income and Growth VCT PLC ("Maven VCT 1"), Maven Income and Growth VCT 2 PLC ("Maven VCT 2"), Maven Income and Growth VCT 3 PLC ("Maven VCT 3"), Maven Income and Growth VCT 4 PLC ("Maven VCT 4") and Maven Income and Growth VCT 5 PLC ("Maven VCT 5") (together "the Companies" and each a "Company"). The Companies are managed by Maven Capital Partners UK LLP ("Maven").

The Boards of the Companies are pleased to announce the launch of the offers for subscription to raise, in aggregate, up to £18 million ("the Offers" and each an "Offer").

Full details of the Offers are contained in a prospectus ("the Prospectus"), which was published by the Companies today.

In contrast to previous offers by Maven VCTs, prospective investors can apply either to invest amounts of their choice in one or more of the Offers or invest an equal amount in each of the Companies pursuant to the Offers (subject to each relevant Offer not having closed prior to the Application Form being processed). The amount subscribed under each Offer will be invested into new ordinary shares of 10p each ("New Shares") in the relevant Company.

The Offers open today and will close at 12.00 noon on 28 April 2015 (unless fully subscribed by an earlier date or otherwise extended or closed at an earlier date at the Directors' discretion). Persons intending to apply under the Offers for the 2014/2015 tax year should note that the deadline for such applications is 12.00 noon on 1 April 2015.

Pursuant to individual offer agreements dated 20 October 2014 relating to each Offer between, among others, each relevant Company and Maven, Maven will receive a fee of an amount equal to 2.5% of the amounts remitted to each Company with an investor's application (including any amounts requested to be facilitated) in respect of applications accepted under that Offer less (i) an amount equal to any early investment incentive discounts being made available by the Company (as set out in the Prospectus) applicable in respect of applications accepted under the relevant Offer, and less (ii) any amounts that Maven has agreed to waive in respect of applications accepted under the relevant Offer. As Maven is a related party of each Company under the Listing Rules, the payment of such fee by each Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

Further, William Nixon and his associates have expressed their intention, prior to the close of the Offers, to subscribe for up to £300,000 under the Offers (up to £60,000 in respect of each Company). As a director (in the case of Maven VCT 2, Maven VCT 3 and Maven VCT 4) or an associate of Maven (in the case of Maven VCT 1 and Maven VCT 5), William Nixon and, therefore, each of his associates, are each a related party of each Company under the Listing Rules and consequently each of these subscriptions is a transaction to which Listing Rule 11.1.10R applies.

The Companies will also shortly be posting to shareholders a joint circular ("the Circular") convening general meetings of the Companies to be held on:

 

· 20 November 2014 at 10.00 a.m. (Maven VCT 1)

· 20 November 2014 at 10.15 a.m. (Maven VCT 2)

· 20 November 2014 at 10.30 a.m. (Maven VCT 3)

· 20 November 2014 at 10.45 a.m. (Maven VCT 4)

· 20 November 2014 at 11.00 a.m. (Maven VCT 5)

 

to propose, amongst other things, granting authorities to the Companies to allot New Shares pursuant to the Offers. The Prospectus has been submitted to the Financial Conduct Authority and copies of the Circular and Prospectus will shortly be available for download from the Companies' websites:

· www.mavencp.com/migvct

· www.mavencp.com/migvct2

· www.mavencp.com/migvct3

· www.mavencp.com/migvct4

· www.mavencp.com/migvct5

 

and from the National Storage Mechanism (http://www.hemscott.com/nsm.do).

For further information, please contact: 

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

 

 

Maven Capital Partners UK LLP

Secretary

20 October 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRBRBDGLDDBGSG
Date   Source Headline
27th Mar 20185:44 pmRNSPublication of Suppl.Prospcts
9th Mar 20184:16 pmRNSAnnual Financial Report
8th Mar 20183:30 pmRNSDividend Declaration
2nd Mar 201812:34 pmRNSStatement re Offer for Subscription
13th Feb 20183:34 pmRNSTransaction in Own Shares
6th Feb 20185:14 pmRNSDirector/PDMR Shareholding
6th Feb 20185:13 pmRNSDirector/PDMR Shareholding
6th Feb 20185:12 pmRNSDirector/PDMR Shareholding
6th Feb 20185:06 pmRNSIssue of Equity
24th Jan 20184:41 pmRNSPublication of Suppl.Prospcts
19th Jan 20183:33 pmRNSNet Asset Value(s)
30th Nov 20174:31 pmRNSIssue of Equity
22nd Nov 20175:06 pmRNSTransaction in Own Shares
21st Nov 20173:45 pmRNSIssue of Equity
17th Nov 20175:05 pmRNSStatement re NAV and Dividend Investment Scheme
8th Nov 201710:11 amRNSResult of General Meeting
27th Oct 20173:26 pmRNSNet Asset Value(s)
25th Oct 20172:57 pmRNSDividend Declaration
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
15th Sep 20174:45 pmRNSIssue of Equity
15th Sep 201710:05 amRNSStatement re NAV and Dividend Investment Scheme
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
31st Aug 20175:01 pmRNSTransaction in Own Shares
25th Aug 20172:29 pmRNSHalf-year Report
10th Aug 20174:31 pmRNSDividend Declaration
25th Jul 201712:55 pmRNSForm 8.3 - Work Group PLC
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
10th Jul 201710:56 amRNSNet Asset Value(s)
15th Jun 20174:00 pmRNSDividend Declaration
12th May 20174:13 pmRNSTransaction in Own Shares
12th May 20174:07 pmRNSNet Asset Value(s)
11th May 20172:39 pmRNSTransaction in Own Shares
10th May 201712:33 pmRNSTransaction in Own Shares
28th Apr 20173:36 pmRNSDirectorate Change
27th Apr 20171:01 pmRNSNet Asset Value(s)
27th Apr 201712:57 pmRNSResult of AGM
24th Mar 20175:33 pmRNSAnnual Financial Report
26th Jan 20177:00 amRNSNet Asset Value and Proposed Final Dividend
20th Jan 201710:12 amRNSDirectorate Change
8th Nov 20164:49 pmRNSTransaction in Own Shares
7th Nov 201611:00 amRNSDirector/PDMR Shareholding
28th Oct 20168:39 amRNSNet Asset Value(s)
26th Aug 20164:36 pmRNSTransaction in Own Shares
21st Jul 20164:53 pmRNSHalf-year Report
13th Apr 20161:14 pmRNSDirectorate Change
13th Apr 20161:08 pmRNSResult of AGM
13th Apr 201612:52 pmRNSNet Asset Value(s)
11th Mar 20167:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.